ALLO CHASSIS Trademark

Research and testing of cell-based products, in particular therapeutic products; research, optimization and testing of cell production processes; laboratory research in the field of biotechnology using genetically modified iPS (induced pluripotent stem) cells and differentiated cells derived therefrom; Scientific research, design and development of scientific cell culture, cell therapy and gene edited cell therapy; Scientific research, design and development of cell culture, cell therapy or gene edited cell therapy, manufacturing systems and manufacturing processes for others; platform as a service (PAAS) services featuring computer software platforms for custom manufacturing of cell-based products, in the field of cell therapy, and cell therapy development; providing temporary use of online non-downloadable computer software platform for the management of manufacturing of cell-based therapies, namely, the associated technology, processes, and data analytics capabilities for process optimization and quality control

Modified cells, in particular genetically modified iPS (induced pluripotent stem) cells and differentiated cells derived therefrom, for research or scientific purposes; cell cultures, cell culture systems and cryopreserved genetically modified iPS cells for scientific and industrial research purposes; cell cultures, and cryopreserved cells iPS cells other than for medical or veterinary use; Biological preparations for use in cell cultures, other than for medical or veterinary purposes, namely, cell culture agents for use in the biotechnology industry and cell material for use in combination with human cells, particularly genetically modified iPS or differentiated stem cells

Modified cells, in particular genetically modified iPS (induced pluripotent stem) cells or differentiated cells derived therefrom, for medical or veterinary use; cell cultures and cell culture systems, and cryopreserved pluripotent stem cells for medical or veterinary use; genetically modified iPS (induced pluripotent stem) cells for use in generating other cells for therapeutic purposes; cell cultures and cell culture systems, and cryopreserved genetically modified pluripotent stem cells for sub cultivation of cells.

Custom manufacturing of iPS derived cells, and iPS derived cell therapy and manufacturing processes for others, namely, manufacturing of the foregoing cells in GMP-based facilities; custom manufacture of therapeutic cells, medicines, cell therapies and gene edited cell therapies for others, namely, manufacturing in GMP-based facilities; custom manufacture of cellular therapies, namely, manufacturing in GMP-based facilities; custom manufacturing of cell lines being modified cells with specific genetic edits for use in generating other cells